You have 9 free searches left this month | for more free features.

Myelodysplasia

Showing 26 - 50 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Oral azacitidine
  • Matched placebo
  • Birmingham, United Kingdom
  • +20 more
Oct 14, 2021

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Duarte, California
  • +10 more
Jul 2, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 15, 2022

AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
Dec 29, 2021

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

Completed
  • Acute Myelogenous Leukemia
  • +4 more
  • Single Umbilical Cord Blood Unit Transplant
  • +6 more
  • Birmingham, Alabama
  • +37 more
Oct 13, 2021

Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

Recruiting
  • Acute Leukemia
  • +2 more
  • Darlinghurst, New South Wales, Australia
  • +8 more
Aug 30, 2021

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
  • Antwerpen, Belgium
  • +21 more
Sep 27, 2021

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    A Post-Marketing Observational Study of VYXEOS™

    Completed
    • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    • Therapy-Related Acute Myeloid Leukemia
    • Indianapolis, Indiana
    • +6 more
    Aug 4, 2020

    Acute Leukemia, Myelodysplasia Trial in United States (Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate, Mobilized

    Completed
    • Acute Leukemia
    • Myelodysplasia
    • Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate
    • +5 more
    • Duarte, California
    • +27 more
    Nov 22, 2021

    MDS, Cardiovascular Diseases, Inflammation Trial in Toronto (Genetic Mutations, Inflammatory and lipid markers, Computed

    Unknown status
    • MDS
    • +2 more
    • Genetic Mutations
    • +2 more
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Sep 30, 2019

    Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

    Completed
    • Myelodysplastic Syndrome (MDS)
    • ON 01910 Na
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

    Completed
    • Acute Myeloid Leukemia
    • +19 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Lewes, Delaware
    • +16 more
    Aug 3, 2022

    High-risk MDS With Excess Blasts Trial in Nancy, Vandoeuvre les Nancy (Myelogram)

    Unknown status
    • High-risk Myelodysplastic Syndromes With Excess Blasts
    • Myelogram
    • Nancy, France
    • +1 more
    Aug 5, 2019

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023

    Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

    Withdrawn
    • Myelodysplastic Syndrome
    • SyB C-1101 and Azacytidine
    • Nagoya, Aichi, Japan
    • +3 more
    Nov 14, 2022

    Erythroid Response in Myelodysplasia Undergoing Chelation

    Unknown status
    • Myelodysplasia
    • +2 more
      • Alessandria, AL, Italy
      • +19 more
      Jul 29, 2019

      Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

      Active, not recruiting
      • Acute Leukemia
      • +3 more
      • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
      • +5 more
      • Birmingham, Alabama
      • +38 more
      Oct 25, 2021

      Moxetumomab Pasudotox-tdfk (LUMOXITI)

      Recruiting
      • Hairy Cell Leukemia
        • Pueblo, Colorado
        • +1 more
        Aug 17, 2022